TAZOCILLINE 2 g/0.25 g, powder for solution for infusion bottle
Active ingredients: Piperacillin, Piperacillin sodium, Tazobactam, Tazobactam sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAZOCILLINE 2 g/0,25 g, poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Aug 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67873780CIP73691921CIP133400936919211Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIPÉRACILLINE SODIQUEpoudre | — | SA |
| TAZOBACTAMpoudre | 0,25 g · un flacon | FT |
| TAZOBACTAM SODIQUEpoudre | — | SA |
| PIPÉRACILLINE BASEpoudre | 2 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.